AI English summary of an SEC filing — figures as filed
P&G said net sales for the 6 months ended December 31, 2023 rose 5% from the prior-year period to $43.3 billion, net earnings were $8.0 billion, and diluted EPS rose 2% to $3.23.
Key points
AI summaryP&G said net sales for the 6 months ended December 31, 2023 rose 5% from the prior-year period to $43.3 billion, net earnings were $8.0 billion, and diluted EPS rose 2% to $3.23.
The company said it recorded a non-cash impairment charge of $1.3 billion before tax ($1.0 billion after tax) on the Gillette intangible asset in the quarter ended December 31, 2023. The company cited a higher discount rate, the weakening of several currencies against the U.S. dollar and the limited market portfolio restructuring as factors.
The company announced a limited market portfolio restructuring in December 2023, primarily in certain Enterprise Markets, including Argentina and Nigeria. It said it expects to record incremental restructuring charges of $1.0 to $1.5 billion after tax. The company said the charges are primarily foreign currency translation losses and that it expects to recognize them in fiscal 2024 and 2025.
The company said operating cash flow for the 6 months ended December 31, 2023 rose $2.4 billion from the prior-year period to $10.0 billion. Adjusted free cash flow was $8.7 billion, and adjusted free cash flow productivity was 96%.
Key figures
Quarter ended December 31, 2023
- Revenue
- $21.4B
- Operating income
- $4.4B
- Net income
- $3.5B
- EPS
- $1.40
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
6-Month Net Sales, Net Earnings and EPS
P&G said net sales for the 6 months ended December 31, 2023 rose 5% from the prior-year period to $43.3 billion, net earnings were $8.0 billion, and diluted EPS rose 2% to $3.23.
Source · Based on the MD&A text of the filing
Gillette Intangible Asset Impairment
The company said it recorded a non-cash impairment charge of $1.3 billion before tax ($1.0 billion after tax) on the Gillette intangible asset in the quarter ended December 31, 2023. The company cited a higher discount rate, the weakening of several currencies against the U.S. dollar and the limited market portfolio restructuring as factors.
Source · Based on the MD&A text of the filing
Limited Market Portfolio Restructuring
The company announced a limited market portfolio restructuring in December 2023, primarily in certain Enterprise Markets, including Argentina and Nigeria. It said it expects to record incremental restructuring charges of $1.0 to $1.5 billion after tax. The company said the charges are primarily foreign currency translation losses and that it expects to recognize them in fiscal 2024 and 2025.
Source · Based on the MD&A text of the filing
6-Month Operating Cash Flow and Free Cash Flow
The company said operating cash flow for the 6 months ended December 31, 2023 rose $2.4 billion from the prior-year period to $10.0 billion. Adjusted free cash flow was $8.7 billion, and adjusted free cash flow productivity was 96%.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…